Froon A H, Bemelmans M H, Greve J W, van der Linden C J, Buurman W A
Department of Surgery, University Hospital Maastricht, University of Limburg, The Netherlands.
Crit Care Med. 1994 May;22(5):803-9. doi: 10.1097/00003246-199405000-00015.
Tumor necrosis factor (TNF) is an important mediator in the complex pathophysiology of sepsis syndrome. Although a positive correlation with mortality rate has been demonstrated, TNF has not been found consistently in sepsis. Since prolonged increases in soluble TNF receptor concentrations were demonstrated after endotoxin and TNF administration, we investigated whether the measurement of TNF receptor concentrations could provide a better indicator of disease than plasma TNF and interleukin (IL)-6 concentrations.
Prospective analysis.
General intensive care unit (ICU) of a university hospital.
Twenty-six patients with sepsis syndrome and proven bacteremia.
Plasma peak concentrations of the soluble 55-kilodalton molecular weight TNF receptor were significantly higher (p < .005) in nonsurvivors compared with survivors of sepsis syndrome, whereas the difference in peak concentrations of the soluble 75-kilodalton TNF receptor did not reach significance (p = .06). In contrast to TNF peak concentrations (p = .14), significantly higher (p < .05) IL-6 peak concentrations were measured in nonsurvivors. Besides the positive correlation between the soluble 55-kilodalton TNF receptor and the soluble 75-kilodalton TNF receptor (r2 = .68; p < .0001), peak concentrations of both soluble 55-kilodalton TNF receptor and 75-kilodalton TNF receptor correlated significantly with plasma creatinine values, an indicator of renal function (r2 = .60; p < .0001 and r2 = .44; p < .001, respectively). Plasma creatinine concentrations were significantly higher in nonsurvivors (p < .001).
In the population studied, plasma-soluble TNF receptor concentrations correlated with outcome as well as with plasma creatinine concentrations. The data presented suggest that increased plasma-soluble TNF receptor concentrations in patients with sepsis syndrome are merely the result of renal failure complicating sepsis, and are similarly correlated with mortality rate.
肿瘤坏死因子(TNF)是脓毒症综合征复杂病理生理学中的重要介质。尽管已证明其与死亡率呈正相关,但在脓毒症中并非总能检测到TNF。由于在内毒素和TNF给药后,可溶性TNF受体浓度会持续升高,我们研究了测量TNF受体浓度是否比血浆TNF和白细胞介素(IL)-6浓度能更好地指示疾病。
前瞻性分析。
大学医院的综合重症监护病房(ICU)。
26例脓毒症综合征且确诊菌血症的患者。
脓毒症综合征非幸存者血浆中可溶性55千道尔顿分子量TNF受体的峰值浓度显著高于幸存者(p <.005),而可溶性75千道尔顿TNF受体峰值浓度的差异未达到显著水平(p =.06)。与TNF峰值浓度(p =.14)相反,非幸存者中测量到的IL-6峰值浓度显著更高(p <.05)。除了可溶性55千道尔顿TNF受体与可溶性75千道尔顿TNF受体呈正相关(r2 =.68;p <.0001)外,可溶性55千道尔顿TNF受体和75千道尔顿TNF受体的峰值浓度均与血浆肌酐值显著相关,血浆肌酐值是肾功能的一个指标(分别为r2 =.60;p <.0001和r2 =.44;p <.001)。非幸存者的血浆肌酐浓度显著更高(p <.001)。
在所研究的人群中,血浆可溶性TNF受体浓度与预后以及血浆肌酐浓度相关。所呈现的数据表明,脓毒症综合征患者血浆可溶性TNF受体浓度升高仅仅是脓毒症并发肾衰竭的结果,且同样与死亡率相关。